Univasc and Taste disturbance - a phase IV clinical study of FDA data

Summary:

Taste disturbance is reported only by a few people who take Univasc.

The phase IV clinical study analyzes which people take Univasc and have Taste disturbance. It is created by eHealthMe based on reports of 967 people who have side effects while taking Univasc from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Apr, 01, 2023

967 people reported to have side effects when taking Univasc.
Among them, 2 people (0.21%) have Taste disturbance.

What is Univasc?

Univasc has active ingredients of moexipril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 982 Univasc users for its effectiveness, alternative drugs and more.

What is Taste disturbance?

Taste disturbance is found to be associated with 1,001 drugs and 2 conditions by eHealthMe.

Number of Univasc and Taste disturbance reports submitted per year:

Gender of people who have Taste disturbance when taking Univasc *:

female: 50 %
male: 50 %

Common side effects people have besides Taste disturbance *:

Fatigue (feeling of tiredness): 1 person, 50.00%
Cough: 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Univasc and have Taste disturbance?

Check whether Taste disturbance is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Taste disturbance and when was it recovered:

Taste disturbance in Univasc

Expand to all the drugs that have ingredients of moexipril hydrochloride:

Taste disturbance and drugs with ingredients of moexipril hydrochloride

Alternative drugs to, pros and cons of Univasc:

Univasc (982 reports)

Taste disturbance treatments and more:

Taste disturbance (4,340 reports)

COVID vaccines that are related to Taste disturbance:

Common drugs associated with Taste disturbance:

All the drugs that are associated with Taste disturbance:

Taste disturbance (1,001 drugs)

All the conditions that are associated with Taste disturbance:

Taste disturbance (2 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on moexipril hydrochloride (the active ingredients of Univasc) and Univasc (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.